Global and China Seasonal Influenza Vaccines Market Insights, Forecast to 2027

Global and China Seasonal Influenza Vaccines Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Seasonal Influenza Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Type
1.2.2 Type A (H1N1)
1.2.3 Type A (H3N2)
1.2.4 Type B
1.3 Market by Application
1.3.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Application
1.3.2 Pediatrics
1.3.3 Adolescence
1.3.4 Adults
1.3.5 Elderly
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Seasonal Influenza Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Seasonal Influenza Vaccines Revenue 2016-2027
2.1.2 Global Seasonal Influenza Vaccines Sales 2016-2027
2.2 Global Seasonal Influenza Vaccines, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Seasonal Influenza Vaccines Historical Market Size by Region (2016-2021)
2.3.1 Global Seasonal Influenza Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Seasonal Influenza Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Seasonal Influenza Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Seasonal Influenza Vaccines Sales Forecast by Region (2022-2027)
2.4.2 Global Seasonal Influenza Vaccines Revenue Forecast by Region (2022-2027)
3 Global Seasonal Influenza Vaccines Competitor Landscape by Players
3.1 Global Top Seasonal Influenza Vaccines Manufacturers by Sales
3.1.1 Global Seasonal Influenza Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Seasonal Influenza Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Seasonal Influenza Vaccines Manufacturers by Revenue
3.2.1 Key Seasonal Influenza Vaccines Manufacturers Covered: Ranking by Revenue
3.2.2 Global Seasonal Influenza Vaccines Revenue by Manufacturers (2016-2021)
3.2.3 Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Seasonal Influenza Vaccines Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Revenue in 2020
3.2.6 Global Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Seasonal Influenza Vaccines Price by Manufacturers
3.4 Global Seasonal Influenza Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Seasonal Influenza Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Seasonal Influenza Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Seasonal Influenza Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Seasonal Influenza Vaccines Market Size by Type (2016-2021)
4.1.1 Global Seasonal Influenza Vaccines Sales by Type (2016-2021)
4.1.2 Global Seasonal Influenza Vaccines Revenue by Type (2016-2021)
4.1.3 Seasonal Influenza Vaccines Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Seasonal Influenza Vaccines Market Size Forecast by Type (2022-2027)
4.2.1 Global Seasonal Influenza Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Seasonal Influenza Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Seasonal Influenza Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Seasonal Influenza Vaccines Market Size by Application (2016-2021)
5.1.1 Global Seasonal Influenza Vaccines Sales by Application (2016-2021)
5.1.2 Global Seasonal Influenza Vaccines Revenue by Application (2016-2021)
5.1.3 Seasonal Influenza Vaccines Price by Application (2016-2021)
5.2 Seasonal Influenza Vaccines Market Size Forecast by Application (2022-2027)
5.2.1 Global Seasonal Influenza Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Seasonal Influenza Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Seasonal Influenza Vaccines Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Seasonal Influenza Vaccines Market Size YoY Growth 2016-2027
6.1.1 China Seasonal Influenza Vaccines Sales YoY Growth 2016-2027
6.1.2 China Seasonal Influenza Vaccines Revenue YoY Growth 2016-2027
6.1.3 China Seasonal Influenza Vaccines Market Share in Global Market 2016-2027
6.2 China Seasonal Influenza Vaccines Market Size by Players (International and Local Players)
6.2.1 China Top Seasonal Influenza Vaccines Players by Sales (2016-2021)
6.2.2 China Top Seasonal Influenza Vaccines Players by Revenue (2016-2021)
6.3 China Seasonal Influenza Vaccines Historic Market Review by Type (2016-2021)
6.3.1 China Seasonal Influenza Vaccines Sales Market Share by Type (2016-2021)
6.3.2 China Seasonal Influenza Vaccines Revenue Market Share by Type (2016-2021)
6.3.3 China Seasonal Influenza Vaccines Price by Type (2016-2021)
6.4 China Seasonal Influenza Vaccines Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Seasonal Influenza Vaccines Sales Forecast by Type (2022-2027)
6.4.2 China Seasonal Influenza Vaccines Revenue Forecast by Type (2022-2027)
6.4.3 China Seasonal Influenza Vaccines Price Forecast by Type (2022-2027)
6.5 China Seasonal Influenza Vaccines Historic Market Review by Application (2016-2021)
6.5.1 China Seasonal Influenza Vaccines Sales Market Share by Application (2016-2021)
6.5.2 China Seasonal Influenza Vaccines Revenue Market Share by Application (2016-2021)
6.5.3 China Seasonal Influenza Vaccines Price by Application (2016-2021)
6.6 China Seasonal Influenza Vaccines Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Seasonal Influenza Vaccines Sales Forecast by Application (2022-2027)
6.6.2 China Seasonal Influenza Vaccines Revenue Forecast by Application (2022-2027)
6.6.3 China Seasonal Influenza Vaccines Price Forecast by Application (2022-2027)
7 North America
7.1 North America Seasonal Influenza Vaccines Market Size YoY Growth 2016-2027
7.2 North America Seasonal Influenza Vaccines Market Facts & Figures by Country
7.2.1 North America Seasonal Influenza Vaccines Sales by Country (2016-2021)
7.2.2 North America Seasonal Influenza Vaccines Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Seasonal Influenza Vaccines Market Size YoY Growth 2016-2027
8.2 Asia Pacific Seasonal Influenza Vaccines Market Facts & Figures by Region
8.2.1 Asia Pacific Seasonal Influenza Vaccines Sales by Region (2016-2021)
8.2.2 Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Seasonal Influenza Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Seasonal Influenza Vaccines Market Facts & Figures by Country
9.2.1 Europe Seasonal Influenza Vaccines Sales by Country (2016-2021)
9.2.2 Europe Seasonal Influenza Vaccines Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Seasonal Influenza Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Seasonal Influenza Vaccines Market Facts & Figures by Country
10.2.1 Latin America Seasonal Influenza Vaccines Sales by Country (2016-2021)
10.2.2 Latin America Seasonal Influenza Vaccines Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Seasonal Influenza Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Seasonal Influenza Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2016-2021)
11.2.2 Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 GlaxoSmithKline plc
12.1.1 GlaxoSmithKline plc Corporation Information
12.1.2 GlaxoSmithKline plc Description and Business Overview
12.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Products Offered
12.1.5 GlaxoSmithKline plc Recent Development
12.2 Sinovac Biotech Ltd
12.2.1 Sinovac Biotech Ltd Corporation Information
12.2.2 Sinovac Biotech Ltd Description and Business Overview
12.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Products Offered
12.2.5 Sinovac Biotech Ltd Recent Development
12.3 Changsheng Bio-Technology
12.3.1 Changsheng Bio-Technology Corporation Information
12.3.2 Changsheng Bio-Technology Description and Business Overview
12.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Products Offered
12.3.5 Changsheng Bio-Technology Recent Development
12.4 Ccbio SA
12.4.1 Ccbio SA Corporation Information
12.4.2 Ccbio SA Description and Business Overview
12.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ccbio SA Seasonal Influenza Vaccines Products Offered
12.4.5 Ccbio SA Recent Development
12.5 Aleph Biomedical
12.5.1 Aleph Biomedical Corporation Information
12.5.2 Aleph Biomedical Description and Business Overview
12.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Aleph Biomedical Seasonal Influenza Vaccines Products Offered
12.5.5 Aleph Biomedical Recent Development
12.6 Sanofi
12.6.1 Sanofi Corporation Information
12.6.2 Sanofi Description and Business Overview
12.6.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sanofi Seasonal Influenza Vaccines Products Offered
12.6.5 Sanofi Recent Development
12.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
12.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
12.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Business Overview
12.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Products Offered
12.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Development
12.8 Dalian Hissen Bio-pharm
12.8.1 Dalian Hissen Bio-pharm Corporation Information
12.8.2 Dalian Hissen Bio-pharm Description and Business Overview
12.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Products Offered
12.8.5 Dalian Hissen Bio-pharm Recent Development
12.9 Abbott Laboratories
12.9.1 Abbott Laboratories Corporation Information
12.9.2 Abbott Laboratories Description and Business Overview
12.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Abbott Laboratories Seasonal Influenza Vaccines Products Offered
12.9.5 Abbott Laboratories Recent Development
12.10 Novartis International AG
12.10.1 Novartis International AG Corporation Information
12.10.2 Novartis International AG Description and Business Overview
12.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis International AG Seasonal Influenza Vaccines Products Offered
12.10.5 Novartis International AG Recent Development
12.11 GlaxoSmithKline plc
12.11.1 GlaxoSmithKline plc Corporation Information
12.11.2 GlaxoSmithKline plc Description and Business Overview
12.11.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Products Offered
12.11.5 GlaxoSmithKline plc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Seasonal Influenza Vaccines Industry Trends
13.2 Seasonal Influenza Vaccines Market Drivers
13.3 Seasonal Influenza Vaccines Market Challenges
13.4 Seasonal Influenza Vaccines Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Seasonal Influenza Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Seasonal Influenza Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Type A (H1N1)
Table 3. Major Manufacturers of Type A (H3N2)
Table 4. Major Manufacturers of Type B
Table 5. Global Seasonal Influenza Vaccines Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Seasonal Influenza Vaccines Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Seasonal Influenza Vaccines Sales by Regions (2016-2021) & (K Units)
Table 8. Global Seasonal Influenza Vaccines Sales Market Share by Regions (2016-2021)
Table 9. Global Seasonal Influenza Vaccines Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Seasonal Influenza Vaccines Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Seasonal Influenza Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Seasonal Influenza Vaccines Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Seasonal Influenza Vaccines Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Seasonal Influenza Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 17. Seasonal Influenza Vaccines Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Seasonal Influenza Vaccines Revenue Share by Manufacturers (2016-2021)
Table 19. Global Seasonal Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccines as of 2020)
Table 21. Key Manufacturers Seasonal Influenza Vaccines Price (2016-2021) (USD/Unit)
Table 22. Seasonal Influenza Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Seasonal Influenza Vaccines Product Type
Table 24. Date of International Manufacturers Enter into Seasonal Influenza Vaccines Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Seasonal Influenza Vaccines Sales by Type (2016-2021) (K Units)
Table 27. Global Seasonal Influenza Vaccines Sales Share by Type (2016-2021)
Table 28. Global Seasonal Influenza Vaccines Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Seasonal Influenza Vaccines Revenue Share by Type (2016-2021)
Table 30. Seasonal Influenza Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global Seasonal Influenza Vaccines Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Seasonal Influenza Vaccines Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Seasonal Influenza Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Seasonal Influenza Vaccines Sales by Application (2016-2021) (K Units)
Table 37. Global Seasonal Influenza Vaccines Sales Share by Application (2016-2021)
Table 38. Global Seasonal Influenza Vaccines Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Seasonal Influenza Vaccines Revenue Share by Application (2016-2021)
Table 40. Seasonal Influenza Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global Seasonal Influenza Vaccines Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Seasonal Influenza Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Seasonal Influenza Vaccines Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. China Seasonal Influenza Vaccines Sales (K Units) of Key Companies (2016-2021)
Table 47. China Seasonal Influenza Vaccines Sales Share by Company (2016-2021)
Table 48. China Seasonal Influenza Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 49. China Seasonal Influenza Vaccines Revenue Share by Company (2016-2021)
Table 50. China Seasonal Influenza Vaccines Sales (K Units) by Type (2016-2021)
Table 51. China Seasonal Influenza Vaccines Sales Share by Type (2016-2021)
Table 52. China Seasonal Influenza Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Seasonal Influenza Vaccines Price (USD/Unit) by Type (2016-2021)
Table 54. China Seasonal Influenza Vaccines Sales (K Units) by Type (2022-2027)
Table 55. China Seasonal Influenza Vaccines Sales Share by Type (2022-2027)
Table 56. China Seasonal Influenza Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Seasonal Influenza Vaccines Revenue Share by Type (2022-2027)
Table 58. China Seasonal Influenza Vaccines Price (USD/Unit) by Type (2022-2027)
Table 59. China Seasonal Influenza Vaccines Sales (K Units) by Application (2016-2021)
Table 60. China Seasonal Influenza Vaccines Sales Share by Application (2016-2021)
Table 61. China Seasonal Influenza Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Seasonal Influenza Vaccines Price (USD/Unit) by Application (2016-2021)
Table 63. China Seasonal Influenza Vaccines Sales (K Units) by Application (2022-2027)
Table 64. China Seasonal Influenza Vaccines Sales Share by Application (2022-2027)
Table 65. China Seasonal Influenza Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Seasonal Influenza Vaccines Revenue Share by Application (2022-2027)
Table 67. China Seasonal Influenza Vaccines Price (USD/Unit) by Application (2022-2027)
Table 68. North America Seasonal Influenza Vaccines Sales by Country (2016-2021) & (K Units)
Table 69. North America Seasonal Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 70. North America Seasonal Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Seasonal Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Seasonal Influenza Vaccines Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Seasonal Influenza Vaccines Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Seasonal Influenza Vaccines Revenue Market Share by Region (2016-2021)
Table 76. Europe Seasonal Influenza Vaccines Sales by Country (2016-2021) & (K Units)
Table 77. Europe Seasonal Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 78. Europe Seasonal Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Seasonal Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 80. Latin America Seasonal Influenza Vaccines Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Seasonal Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Seasonal Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Seasonal Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Seasonal Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 88. GlaxoSmithKline plc Corporation Information
Table 89. GlaxoSmithKline plc Description and Business Overview
Table 90. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. GlaxoSmithKline plc Seasonal Influenza Vaccines Product
Table 92. GlaxoSmithKline plc Recent Development
Table 93. Sinovac Biotech Ltd Corporation Information
Table 94. Sinovac Biotech Ltd Description and Business Overview
Table 95. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Sinovac Biotech Ltd Product
Table 97. Sinovac Biotech Ltd Recent Development
Table 98. Changsheng Bio-Technology Corporation Information
Table 99. Changsheng Bio-Technology Description and Business Overview
Table 100. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Changsheng Bio-Technology Product
Table 102. Changsheng Bio-Technology Recent Development
Table 103. Ccbio SA Corporation Information
Table 104. Ccbio SA Description and Business Overview
Table 105. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Ccbio SA Product
Table 107. Ccbio SA Recent Development
Table 108. Aleph Biomedical Corporation Information
Table 109. Aleph Biomedical Description and Business Overview
Table 110. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Aleph Biomedical Product
Table 112. Aleph Biomedical Recent Development
Table 113. Sanofi Corporation Information
Table 114. Sanofi Description and Business Overview
Table 115. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Sanofi Product
Table 117. Sanofi Recent Development
Table 118. Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
Table 119. Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Business Overview
Table 120. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Jiangsu Simcere Vaxtec Bio-pharmaceutical Product
Table 122. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Development
Table 123. Dalian Hissen Bio-pharm Corporation Information
Table 124. Dalian Hissen Bio-pharm Description and Business Overview
Table 125. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Dalian Hissen Bio-pharm Product
Table 127. Dalian Hissen Bio-pharm Recent Development
Table 128. Abbott Laboratories Corporation Information
Table 129. Abbott Laboratories Description and Business Overview
Table 130. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Abbott Laboratories Product
Table 132. Abbott Laboratories Recent Development
Table 133. Novartis International AG Corporation Information
Table 134. Novartis International AG Description and Business Overview
Table 135. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Novartis International AG Product
Table 137. Novartis International AG Recent Development
Table 138. Seasonal Influenza Vaccines Market Trends
Table 139. Seasonal Influenza Vaccines Market Drivers
Table 140. Seasonal Influenza Vaccines Market Challenges
Table 141. Seasonal Influenza Vaccines Market Restraints
Table 142. Seasonal Influenza Vaccines Customers List
Table 143. Seasonal Influenza Vaccines Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Seasonal Influenza Vaccines Product Picture
Figure 2. Global Seasonal Influenza Vaccines Sales Market Share by Type in 2020 & 2027
Figure 3. Type A (H1N1) Product Picture
Figure 4. Type A (H3N2) Product Picture
Figure 5. Type B Product Picture
Figure 6. Global Seasonal Influenza Vaccines Sales Market Share by Application in 2020 & 2027
Figure 7. Pediatrics
Figure 8. Adolescence
Figure 9. Adults
Figure 10. Elderly
Figure 11. Seasonal Influenza Vaccines Report Years Considered
Figure 12. Global Seasonal Influenza Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Seasonal Influenza Vaccines Market Size 2016-2027 (US$ Million)
Figure 14. Global Seasonal Influenza Vaccines Sales 2016-2027 (K Units)
Figure 15. Global Seasonal Influenza Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Seasonal Influenza Vaccines Sales Market Share by Region (2016-2021)
Figure 17. Global Seasonal Influenza Vaccines Sales Market Share by Region in 2020
Figure 18. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2016-2021)
Figure 19. Global Seasonal Influenza Vaccines Revenue Market Share by Region in 2020
Figure 20. Global Seasonal Influenza Vaccines Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Seasonal Influenza Vaccines Revenue in 2020
Figure 22. Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Seasonal Influenza Vaccines Sales Market Share by Type (2016-2021)
Figure 24. Global Seasonal Influenza Vaccines Sales Market Share by Type in 2020
Figure 25. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2016-2021)
Figure 26. Global Seasonal Influenza Vaccines Revenue Market Share by Type in 2020
Figure 27. Global Seasonal Influenza Vaccines Sales Market Share by Application (2016-2021)
Figure 28. Global Seasonal Influenza Vaccines Sales Market Share by Application in 2020
Figure 29. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2016-2021)
Figure 30. Global Seasonal Influenza Vaccines Revenue Market Share by Application in 2020
Figure 31. China Seasonal Influenza Vaccines Sales Growth Rate 2016-2027 (K Units)
Figure 32. China Seasonal Influenza Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China Seasonal Influenza Vaccines Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest Seasonal Influenza Vaccines Players Market Share by Revenue in Seasonal Influenza Vaccines in 2020
Figure 35. China Seasonal Influenza Vaccines Revenue Share by Type (2016-2021)
Figure 36. China Seasonal Influenza Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China Seasonal Influenza Vaccines Revenue Share by Application (2016-2021)
Figure 38. China Seasonal Influenza Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Seasonal Influenza Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 40. North America Seasonal Influenza Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Seasonal Influenza Vaccines Sales Market Share by Country in 2020
Figure 42. North America Seasonal Influenza Vaccines Revenue Market Share by Country in 2020
Figure 43. U.S. Seasonal Influenza Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 44. U.S. Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Seasonal Influenza Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 46. Canada Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Seasonal Influenza Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 48. Europe Seasonal Influenza Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Seasonal Influenza Vaccines Sales Market Share by Country in 2020
Figure 50. Europe Seasonal Influenza Vaccines Revenue Market Share by Country in 2020
Figure 51. Germany Seasonal Influenza Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 52. Germany Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Seasonal Influenza Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 54. France Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Seasonal Influenza Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 56. U.K. Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Seasonal Influenza Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 58. Italy Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Seasonal Influenza Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 60. Russia Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Seasonal Influenza Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 62. Asia Pacific Seasonal Influenza Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Seasonal Influenza Vaccines Sales Market Share by Region in 2020
Figure 64. Asia Pacific Seasonal Influenza Vaccines Revenue Market Share by Region in 2020
Figure 65. China Seasonal Influenza Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 66. China Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Seasonal Influenza Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 68. Japan Seasonal Influenza Vaccines Revenue Growth Rate (20

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs